New questions are being raised about the clinical trial of a widely used heart drug, and critics are calling for an independent investigation, after a medical device used during the study was later ...

LONDON (Reuters) - Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker. The company's blockbuster Xarelto ...

The quality and depth of clinical trials of the blood-thinner Xarelto could be a key issue when the first trials over the drug begin in Philadelphia courtrooms. With the first trial of more than 800 ...

Johnson & Johnson will begin offering four prescription drugs, including diabetes treatments Invokamet, Invokamet XR, Invokana, and blood thinner Xarelto, on the Trump administration’s TrumpRx website ...

Blackstone Life Sciences’ $250 million bet on an ex-Novartis drug candidate has racked up another phase 2 win. The data show Anthos Therapeutics’ abelacimab significantly cut bleeding compared to ...

Pune, April 18, 2022 (GLOBE NEWSWIRE) -- Global Xarelto Market research report 2022-2028 is a professional and in-depth study on the current state of the global Xarelto industry with a focus on the ...

To receive coverage for Xarelto, a person must be enrolled in a Medicare Part D prescription drug plan or a Medicare Advantage (Part C) plan that includes prescription drug coverage. This article ...

(CBS/AP) The FDA has approved a "next generation" blood thinner called Xarelto for the treatment of atrial fibrillation, a common heart disorder that can lead to stroke. Atrial fibrillation, a.k.a.

RARITAN, N.J., Feb. 5, 2013 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. (Janssen) today announced a clinical collaboration agreement with Portola Pharmaceuticals, Inc. and Bayer HealthCare to ...

XARELTO® is the only new oral anticoagulant with FDA approval in this indication Raritan, NJ (July 1, 2011) /PRNewswire/ - Janssen Pharmaceuticals, Inc. announced today that the U.S. Food and Drug ...